Ferrari NV (NYSE:RACE) reported second-quarter FY22 sales growth of 24.9% year-on-year to €1.291 billion. Total shipments of 3,455 units improved 28.7% from…
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) announced that over 35 physicians have written 50+ prescriptions for Imcivree (setmelanotide) for Bardet-Biedl syndrome…
Zebra Technologies Corp (NASDAQ:ZBRA) reported second-quarter FY22 net sales growth of 6.6% year-on-year to $1.47 billion, beating the consensus of $1.44…